Two potential IBD therapies

As reported previously (see here) Israel’s Biomica is using the human microbiome (stomach bacteria) to fight cancer, IBD, acne etc. Bionica is starting pre-clinical studies for BMC321 & BMC322, two developed microbial consortia aimed to treat Inflammatory Bowel Disease (IBD).

https://www.biomicamed.com/press-releases/biomica-initiates-pre-clinical-studies-in-its-immuno-oncology-program/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *